These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 31178964)
21. High Sodium-Induced Oxidative Stress and Poor Anticrystallization Defense Aggravate Calcium Oxalate Crystal Formation in Rat Hyperoxaluric Kidneys. Huang HS; Ma MC PLoS One; 2015; 10(8):e0134764. PubMed ID: 26241473 [TBL] [Abstract][Full Text] [Related]
22. Deposition of calcium phosphate and calcium oxalate crystals in the kidneys. Khan SR; Glenton PA J Urol; 1995 Mar; 153(3 Pt 1):811-7. PubMed ID: 7861545 [TBL] [Abstract][Full Text] [Related]
23. Metformin ameliorates calcium oxalate crystallization and stone formation by activating the Nrf2/HO-1 signaling pathway: Two birds with one stone. Zhang X; Liang F; Li T; Jiang Y; Ren F Arch Biochem Biophys; 2023 May; 739():109568. PubMed ID: 36914110 [TBL] [Abstract][Full Text] [Related]
24. Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations. Khan SR J Urol; 2013 Mar; 189(3):803-11. PubMed ID: 23022011 [TBL] [Abstract][Full Text] [Related]
25. Chronic L-arginine administration increases oxidative and nitrosative stress in rat hyperoxaluric kidneys and excessive crystal deposition. Huang HS; Ma MC; Chen J Am J Physiol Renal Physiol; 2008 Aug; 295(2):F388-96. PubMed ID: 18448592 [TBL] [Abstract][Full Text] [Related]
26. Inhalation of hydrogen gas ameliorates glyoxylate-induced calcium oxalate deposition and renal oxidative stress in mice. Peng Z; Chen W; Wang L; Ye Z; Gao S; Sun X; Guo Z Int J Clin Exp Pathol; 2015; 8(3):2680-9. PubMed ID: 26045773 [TBL] [Abstract][Full Text] [Related]
27. Strain differences in urinary factors that promote calcium oxalate crystal formation in the kidneys of ethylene glycol-treated rats. Li Y; McMartin KE Am J Physiol Renal Physiol; 2009 May; 296(5):F1080-7. PubMed ID: 19244400 [TBL] [Abstract][Full Text] [Related]
28. Identification of Resolvin D1 and Protectin D1 as Potential Therapeutic Agents for Treating Kidney Stones. Wang B; Wei J; Huangfu Q; Gao F; Qin L; Zhong J; Wen J; Ye Z; Yang X; Liu H Oxid Med Cell Longev; 2022; 2022():4345037. PubMed ID: 35251472 [TBL] [Abstract][Full Text] [Related]
29. H19 promote calcium oxalate nephrocalcinosis-induced renal tubular epithelial cell injury via a ceRNA pathway. Liu H; Ye T; Yang X; Liu J; Jiang K; Lu H; Xia D; Peng E; Chen Z; Sun F; Tang K; Ye Z EBioMedicine; 2019 Dec; 50():366-378. PubMed ID: 31735555 [TBL] [Abstract][Full Text] [Related]
30. miR-155-5p Promotes Oxalate- and Calcium-Induced Kidney Oxidative Stress Injury by Suppressing MGP Expression. Jiang K; Hu J; Luo G; Song D; Zhang P; Zhu J; Sun F Oxid Med Cell Longev; 2020; 2020():5863617. PubMed ID: 32215174 [TBL] [Abstract][Full Text] [Related]
31. Glycine suppresses kidney calcium oxalate crystal depositions via regulating urinary excretions of oxalate and citrate. Lan Y; Zhu W; Duan X; Deng T; Li S; Liu Y; Yang Z; Wen Y; Luo L; Zhao S; Wang J; Zhao Z; Wu W; Zeng G J Cell Physiol; 2021 Oct; 236(10):6824-6835. PubMed ID: 33772775 [TBL] [Abstract][Full Text] [Related]
32. p53 deacetylation alleviates calcium oxalate deposition-induced renal fibrosis by inhibiting ferroptosis. Ye Z; Xia Y; Li L; Li B; Chen L; Yu W; Ruan Y; Rao T; Zhou X; Cheng F Biomed Pharmacother; 2023 Aug; 164():114925. PubMed ID: 37236026 [TBL] [Abstract][Full Text] [Related]
33. Trimethylamine N-oxide promotes hyperoxaluria-induced calcium oxalate deposition and kidney injury by activating autophagy. Dong F; Jiang S; Tang C; Wang X; Ren X; Wei Q; Tian J; Hu W; Guo J; Fu X; Liu L; Patzak A; Persson PB; Gao F; Lai EY; Zhao L Free Radic Biol Med; 2022 Feb; 179():288-300. PubMed ID: 34767921 [TBL] [Abstract][Full Text] [Related]
34. Metabolomic analysis reveals a protective effect of Fu-Fang-Jin-Qian-Chao herbal granules on oxalate-induced kidney injury. Chen W; Liu WR; Hou JB; Ding JR; Peng ZJ; Gao SY; Dong X; Ma JH; Lin QS; Lu JR; Guo ZY Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30737304 [TBL] [Abstract][Full Text] [Related]
35. CREB1 protects against the renal injury in a rat model of kidney stone disease and calcium oxalate monohydrate crystals-induced injury in NRK-52E cells. Yu L; Gan X; Bai Y; An R Toxicol Appl Pharmacol; 2021 Feb; 413():115394. PubMed ID: 33421503 [TBL] [Abstract][Full Text] [Related]
36. Total flavonoids of Desmodium styracifolium attenuates the formation of hydroxy-L-proline-induced calcium oxalate urolithiasis in rats. Zhou J; Jin J; Li X; Zhao Z; Zhang L; Wang Q; Li J; Zhang Q; Xiang S Urolithiasis; 2018 Jun; 46(3):231-241. PubMed ID: 28567512 [TBL] [Abstract][Full Text] [Related]
37. Mechanism of Deng JW; Li CY; Huang YP; Liu WF; Zhang Q; Long J; Wu WQ; Huang LH; Zeng GH; Sun XY J Agric Food Chem; 2024 Mar; 72(12):6372-6388. PubMed ID: 38471112 [TBL] [Abstract][Full Text] [Related]
38. A comparative study on several models of experimental renal calcium oxalate stones formation in rats. Liu J; Cao Z; Zhang Z; Zhou S; Ye Z J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):83-7. PubMed ID: 17393118 [TBL] [Abstract][Full Text] [Related]
39. The SOX4/EZH2/SLC7A11 signaling axis mediates ferroptosis in calcium oxalate crystal deposition-induced kidney injury. Yan X; Xia Y; Li B; Ye Z; Li L; Yuan T; Song B; Yu W; Rao T; Ning J; Lin F; Mei S; Mao Z; Zhou X; Li W; Cheng F J Transl Med; 2024 Jan; 22(1):9. PubMed ID: 38169402 [TBL] [Abstract][Full Text] [Related]